These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15197886)

  • 1. [Changes in coagulation, fibrinolysis and platelet functions during extracorporeal circulation].
    Kaizu K; Uriu K; Ikeda M
    Nihon Rinsho; 2004 May; 62 Suppl 5():46-9. PubMed ID: 15197886
    [No Abstract]   [Full Text] [Related]  

  • 2. Extracorporeal anticoagulation using a serine protease inhibitor in hemodialysis in sheep.
    Mottaghy K; Oedekoven B; Bey R; Schmid-Schönbein H
    Trans Am Soc Artif Intern Organs; 1985; 31():534-6. PubMed ID: 3939276
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anticoagulation for plasmapheresis].
    Amemiya H; Sekihara H; Kobayashi T; Koiwa F; Niikura K
    Nihon Rinsho; 2004 May; 62 Suppl 5():323-7. PubMed ID: 15197938
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anticoagulation in hemodialysis with a single dose of low molecular weight heparin].
    Vukusich A; Avalos C; Orellana G; Cifuentes C; Rivas J; Calderón F
    Rev Med Chil; 1995 Jun; 123(6):735-41. PubMed ID: 8525227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of a serine protease inhibitor, nafamostat mesilate, on plasma coagulation, and platelet activation during experimental Extracorporeal Life Support (ECLS).
    Mellgren K; Skogby M; Friberg LG; Tengborn L; Wadenvik H
    Thromb Haemost; 1998 Feb; 79(2):342-7. PubMed ID: 9493588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. About the effect of low-molecular-weight heparin on platelet function in haemodialysis patients.
    Eleftheriadis T; Antoniadi G; Liakopoulos V; Stefanidis I
    Nephrol Dial Transplant; 2009 Mar; 24(3):1063-4. PubMed ID: 19131348
    [No Abstract]   [Full Text] [Related]  

  • 7. [Heparin in surgery and artificial circulation: pro and contra. Is there an alternative?].
    Roĭtman EV; Dement'eva II; Meshcheriakov AV
    Anesteziol Reanimatol; 1997; (6):65-9. PubMed ID: 9511253
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anticoagulation].
    Matsuda O
    Nihon Rinsho; 1991 Dec; 49 Suppl():279-86. PubMed ID: 1808269
    [No Abstract]   [Full Text] [Related]  

  • 9. Gabexate mesilate (Foy) as an anticoagulant in extracorporeal circulation in dogs and sheep.
    Oedekoven B; Bey R; Mottaghy K; Schmid-Schönbein H
    Thromb Haemost; 1984 Dec; 52(3):329-32. PubMed ID: 6442472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins].
    Delsart D; Chambefort V; Decousus H
    Rev Prat; 2001 Sep; 51(13):1489-97. PubMed ID: 11601082
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of surface-bound and intravenously administered heparin on cell-surface interactions: inflammation and coagulation.
    Johnson G; Curry B; Cahalan L; Prater R; Biggerstaff J; Hussain A; Gartner M; Cahalan P
    Perfusion; 2013 May; 28(3):263-71. PubMed ID: 23401339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application of gabexate mesilate on measurement of coagulation and fibrinolysis. --The effect of high molecular weight Fbg/Fb complex in plasma-- (author's transl)].
    Suzuki S; Tahara C; Kazama M
    Rinsho Byori; 1981 Apr; 29(4):404-8. PubMed ID: 6798246
    [No Abstract]   [Full Text] [Related]  

  • 13. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion.
    Wachtfogel YT; Kucich U; Hack CE; Gluszko P; Niewiarowski S; Colman RW; Edmunds LH
    J Thorac Cardiovasc Surg; 1993 Jul; 106(1):1-9; discussion 9-10. PubMed ID: 7686593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The protease inhibitor gabexate mesilate in experimentally-induced acute pancreatitis with early gram-negative infection in the Göttingen minipig: therapeutic efficacy and effects on blood coagulation and fibrinolysis].
    Heitz J; Semsch B; Emde C; Jansen U; Schäfer JH
    Z Gastroenterol; 1990 Apr; 28(4):192-7. PubMed ID: 2119091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contaminated heparin-affected patient plasmas are associated with activated contact systems.
    Yi Qian ; Jing Pan ; Xiaodong Zhou ; Weiser P; Hong Lu ; Beck AM; Shih FF; Lijuan Zhang
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):261-5. PubMed ID: 20547554
    [No Abstract]   [Full Text] [Related]  

  • 16. [How to use anticoagulants in hemodialysis therapy].
    Uriu K; Kaizu K
    Nihon Rinsho; 2004 May; 62 Suppl 5():163-7. PubMed ID: 15197908
    [No Abstract]   [Full Text] [Related]  

  • 17. Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects.
    Scheuch G; Brand P; Meyer T; Herpich C; Müllinger B; Brom J; Weidinger G; Kohlhäufl M; Häussinger K; Spannagl M; Schramm W; Siekmeier R
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):603-14. PubMed ID: 18204174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Beneficial characteristics of protease inhibitor as an anticoagulant for extracorporeal circulation].
    Akizawa T
    Rinsho Ketsueki; 1990 Jun; 31(6):782-6. PubMed ID: 2214168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulation-fibrinolysis changes during off-pump bypass: effect of two heparin doses.
    Paparella D; Semeraro F; Scrascia G; Galeone A; Ammollo CT; Kounakis G; de Luca Tupputi Schinosa L; Semeraro N; Colucci M
    Ann Thorac Surg; 2010 Feb; 89(2):421-7. PubMed ID: 20103314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Low-dose calcium-heparin prophylaxis in thoracic surgery. Bleeding, changes in coagulation and fibrinolysis].
    Marchetti V; Beati C; Pogliani EM; Vincre G
    Minerva Med; 1983 Jul; 74(28-29):1745-8. PubMed ID: 6866306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.